Intuitive Surgical: FY25 Q2 earnings call, Jul 22, 2025
No Kalshi or Polymarket word markets were listed for Intuitive Surgical’s Jul 22, 2025 earnings call (FY25 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
10 matches for “Ion”; 5 quoted, at least 25 words apart.
…macro challenges in Japan, China and Europe continued. We also placed 54 Ion systems in the quarter. System utilization, defined as procedures per installed clinical…
…in international markets, enhancing core capability and improving product costs. Moving to Ion. Procedures grew 52% to approximately 35,000 in the quarter. We recently sold…
…globally and average system utilization rose by 2%. Taking da Vinci and Ion together, total procedure growth was 18% Strength in Q2 financial results reflected…
…enabler for SP adoption in colorectal and thoracic procedures. Now turning to Ion. We performed approximately 35,000 Ion procedures in Q2, a 52% increase over…
…including depreciation related to new manufacturing capacity, a greater mix of lower-margin Ion and da Vinci 5 revenue and higher service costs related to da…
Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2025-07-22:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2025-07-22:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP